BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2009
View Archived Issues
Shionogi-GlaxoSmithKline revises criteria for S/GSK-1349572 AIDS trial
Read More
Arete Therapeutics describes sEH inhibitors for the treatment of hypertension
Read More
Novel TRPA1 antagonists discovered at Abbott for the treatment of pain
Read More
University of Sheffield divulges new compounds for treating motor neuron diseases
Read More
PharmaMar discovers a new series of oncolytic compounds
Read More
Molecular InSight discloses carbonic anhydrase IX inhibitors for cancer therapy
Read More
New protease inhibitors for hepatitis C virus therapy reported by Enanta
Read More
Inovio and NIH enter research collaboration to develop universal influenza vaccines
Read More
Schering-Plough reports second quarter 2009 results
Read More
Oxygen to commence phase II Oxycyte trial in traumatic brain injury
Read More
AEterna reports results from two phase III cetrorelix studies in BPH
Read More
FDA approves Extavia for multiple sclerosis
Read More
NeuroSearch forms drug discovery and development alliance with Janssen
Read More
Antisense presents new data on ATL-1101 activity in prostate cancer cell lines
Read More
Lilly submits NDA in Japan for GLP-1 receptor agonist exenatide for diabetes
Read More
Onyx to progress oncology compound ONX-0801 into clinical development
Read More
Santhera acquires Juvantia and rights to fipamezole
Read More
Novel JAK2 inhibitors identified at Abbott for cancer
Read More
PDE10A inhibitors developed in Biotie/Wyeth partnership for schizophrenia
Read More
Ultra-low-molecular-weight heparin RO-14 evaluated in humans for the first time
Read More
Long-acting formulation of 2-methoxyestradiol safe in phase I study
Read More
Epigallocatechin gallate a possible treatment for Duchenne muscular dystrophy
Read More
NRX-194204 well tolerated in phase I/II solid tumors and NSCLC trial
Read More
Study finds NPI-2358-docetaxel combination feasible in non-small cell lung cancer
Read More
Phase II data on AT-101 with docetaxel in non-small cell lung cancer presented
Read More
